Phase II study of BK1304 in healthy adults

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223352

Enrollment

600

Registered

2016-10-20

Start date

2016-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of influenza

Interventions

investigational material(s) Generic name etc : BK1304 INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : 2 doses of in

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Written informed consent is obtained from subject

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Efficacy	—

Secondary

Measure	Time frame
Immunogenicity, Safety	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026